Advances in the Management of Chronic Lymphocytic Leukemia
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Hematology".
Deadline for manuscript submissions: 12 May 2026 | Viewed by 23
Special Issue Editors
Interests: chronic lymphocytic leukemia; lymphoproliferative disorders; prognostic factors; targeted therapy; CAR T cell; elderly patients
Interests: chronic lymphocytic leukemia; lymphoproliferative disorders; prognostic factors; targeted therapy; CAR T cell; stem cell transplantation; translational medicine
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The outcomes of patients with chronic lymphocytic leukemia (CLL) have significantly improved over the last few years due to recent advancements in therapeutic and clinical approaches. The implementation of targeted therapies has revolutionized treatment algorithms, eliminating the need for chemotherapy. Nevertheless, there is still a need for new prognostic and predictive factors, and the assessment of comorbidities, fragility, and other potential risk factors, such as infectious, cardiovascular, and metabolic risks, is of increasing importance for further personalizing treatment regimens, thereby enhancing patient outcomes.
We invite you to contribute to a Special Issue of the Journal of Clinical Medicine, focusing on the theme of Advances in the Management of Chronic Lymphocytic Leukemia. This Special Issue will explore novel diagnostic and prognostic markers, as well as recent therapeutic advancements in CLL. Authors are invited to submit original research studies and review articles on these topics. The topics of interest include, but are not limited to, the following:
- Advances in CLL management;
- Targeted therapies and novel therapeutic strategies in CLL;
- Prognostic and predictive factors in CLL;
- Measurable residual disease in CLL;
- Drug resistance in CLL.
We look forward to receiving your contributions.
Dr. Alberto Fresa
Dr. Luca Laurenti
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- chronic lymphocytic leukemia
- lymphoproliferative disorders
- prognostic factors
- targeted therapy
- CAR T cell
- elderly patients
- comorbidities
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
